
₹16 crore drug is the hope for SMA patients
The Hindu
A gene therapy costing ₹16 crore is the only shot of life for nearly 200 children with Spinal Muscular Atrophy (SMA) Type 1, a rare genetic disease, in Karnataka.
More Related News

JSS College of Pharmacy, Mysuru hosted a stakeholder briefing under the IMPACT-VIP programme, a Japan-India collaboration supported by JICA, on January 19. The session brought together government, international partners and representatives of the visually-impaired community to address one central issue: how people with visual impairment manage medicines safely in everyday life.












